Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 FUNCTIONALITY LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 PESTEL
3.2 PORTER'S FIVE FORCES MODEL
3.3 INDUSTRIAL INSIGHTS:
4 ASIA PACIFIC PHARMACEUTICAL EXCIPIENT MARKET: REGULATIONS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISE IN GENERIC DRUG PRODUCTION AND USES
5.1.2 THE SURGE IN DEMAND FOR EXCIPIENTS
5.1.3 TECHNOLOGICAL ADVANCEMENTS IN MULTIFUNCTIONAL EXCIPIENTS
5.1.4 RISING FOCUS ON ORPHAN DRUGS
5.2 RESTRAINTS
5.2.1 INCREASING REGULATORY STRINGENCY REGARDING THE APPROVAL OF DRUGS AND EXCIPIENTS
5.2.2 HIGH PRODUCTION COST
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
5.3.2 RISING DEMAND FOR EASE OF USE
5.3.3 RISING DISPOSABLE INCOME
5.3.4 INCREASING DEMAND FOR ALTERNATIVE ROUTES OF DELIVERY/DOSAGE FORMS
5.4 CHALLENGES
5.4.1 ASSOCIATED SIDE EFFECTS
5.4.2 SAFETY CONSIDERATION OF PHARMACEUTICAL EXCIPIENTS IN STORAGE & TRANSPORTATION
5.4.3 LACK OF NOVEL PHARMACEUTICAL PHARMACEUTICAL EXCIPIENTS
6 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY
6.1 OVERVIEW
6.2 BINDERS AND ADHESIVES
6.2.1 ORGANIC
6.2.2 INORGANIC
6.3 DISINTEGRANTS
6.3.1 ORGANIC
6.3.2 INORGANIC
6.4 COATING MATERIAL
6.4.1 ORGANIC
6.4.2 INORGANIC
6.5 COLORING AGENTS
6.5.1 ORGANIC
6.5.2 INORGANIC
6.6 SOLUBILIZERS
6.6.1 ORGANIC
6.6.2 INORGANIC
6.7 FLAVORS
6.7.1 ORGANIC
6.7.2 INORGANIC
6.8 SWEETENING AGENTS
6.8.1 ORGANIC
6.8.2 INORGANIC
6.9 DILUENTS
6.9.1 ORGANIC
6.9.2 INORGANIC
6.1 LUBRICANTS
6.10.1 ORGANIC
6.10.2 INORGANIC
6.11 BUFFERS
6.11.1 ORGANIC
6.11.2 INORGANIC
6.12 EMULSIFYING AGENTS
6.12.1 ORGANIC
6.12.2 INORGANIC
6.13 PRESERVATIVES
6.13.1 ORGANIC
6.13.2 INORGANIC
6.14 ANTIOXIDANTS
6.14.1 ORGANIC
6.14.2 INORGANIC
6.15 SORBENTS
6.15.1 ORGANIC
6.15.2 INORGANIC
6.16 SOLVENTS
6.16.1 ORGANIC
6.16.2 INORGANIC
6.17 EMOLLIENTS
6.17.1 ORGANIC
6.17.2 INORGANIC
6.18 GLIDENTS
6.18.1 ORGANIC
6.18.2 INORGANIC
6.19 CHELATING AGENTS
6.19.1 ORGANIC
6.19.2 INORGANIC
6.2 ANTIFOAMING AGENTS
6.20.1 ORGANIC
6.20.2 INORGANIC
6.21 OTHERS
7 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET, BY DOSAGE FORM
7.1 OVERVIEW
7.2 SOLID
7.2.1 PLANT
7.2.2 ANIMALS
7.2.3 SYNTHETIC
7.2.4 MINERALS
7.3 SEMI-SOLID
7.3.1 PLANT
7.3.2 ANIMALS
7.3.3 SYNTHETIC
7.3.4 MINERALS
7.4 LIQUID
7.4.1 PLANT
7.4.2 ANIMALS
7.4.3 SYNTHETIC
7.4.4 MINERALS
8 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION
8.1 OVERVIEW
8.2 ORAL EXCIPIENTS
8.3 TOPICAL EXCIPIENTS
8.4 PARENTERAL EXCIPIENTS
8.5 OTHER EXCIPIENTS
9 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 DIRECT TENDER
9.2.1 COMPANY TENDER
9.2.2 TENDER THROUGH MARCH MERCHANDISER
9.3 RETAIL SALES
9.4 OTHERS
10 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
10.3 CONTRACT FORMULATORS
10.4 RESEARCH ORGANIZATION
10.5 OTHERS
11 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION
11.1 ASIA-PACIFIC
11.1.1 CHINA
11.1.2 JAPAN
11.1.3 INDIA
11.1.4 SOUTH KOREA
11.1.5 AUSTRALIA
11.1.6 SINGAPORE
11.1.7 THAILAND
11.1.8 INDONESIA
11.1.9 PHILIPPINES
11.1.10 MALAYSIA
11.1.11 VIETNAM
11.1.12 REST OF ASIA-PACIFIC
12 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 DOW
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 ROQUETTE FRÈRES.
14.2.1 COMPANY SNAPSHOT
14.2.2 COMPANY SHARE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENTS
14.3 EVONIK
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 THE LUBRIZOL CORPORATION
14.4.1 COMPANY SNAPSHOT
14.4.2 COMPANY SHARE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 BASF SE
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 ASHLAND (2021)
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENTS
14.7 AVANTOR, INC.
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENTS
14.8 BENEO
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 CARGILL, INCORPORATED.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 CHEMIE TRADE
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 COLORCON
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 CRODA INTERNATIONAL PLC
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENTS
14.13 DFE PHARMA (SUBSIDIARY OF ROYAL FRIESLANDCAMPINA N.V)
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENTS
14.14 KERRY GROUP PLC.
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENTS
14.15 MEGGLE GMBH & CO. KG
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.16 OMYA AG
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 PETER GREVEN GMBH & CO. KG
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENTS
14.18 PFANSTIEHL
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 2 ASIA PACIFIC BINDERS AND ADHESIVES IN PHARMACEUTICAL EXCIPIENTS MARKETS, BY REGION, 2015-2029 (USD MILLION)
TABLE 3 ASIA PACIFIC BINDERS AND ADHESIVES IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 4 ASIA PACIFIC DISINTEGRANTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 5 ASIA PACIFIC DISINTEGRANTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 6 ASIA PACIFIC COATING MATERIAL IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 7 ASIA PACIFIC COATING MATERIAL IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 8 ASIA PACIFIC COLORING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 9 ASIA PACIFIC COLORING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 10 ASIA PACIFIC SOLUBILIZERS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 11 ASIA PACIFIC SOLUBILIZERS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 12 ASIA PACIFIC FLAVORS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 13 ASIA PACIFIC FLAVORS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 14 ASIA PACIFIC SWEETENING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 15 ASIA PACIFIC SWEETENING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 16 ASIA PACIFIC DILUENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 17 ASIA PACIFIC DILUENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 18 ASIA PACIFIC LUBRICANTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 19 ASIA PACIFIC LUBRICANTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 20 ASIA PACIFIC BUFFERS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 21 ASIA PACIFIC BUFFERS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 22 ASIA PACIFIC EMULSIFYING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 23 ASIA PACIFIC EMULSIFYING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 24 ASIA PACIFIC PRESERVATIVES IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 25 ASIA PACIFIC PRESERVATIVES IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 26 ASIA PACIFIC ANTIOXIDANTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 27 ASIA PACIFIC ANTIOXIDANTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 28 ASIA PACIFIC SORBENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 29 ASIA PACIFIC SORBENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 30 ASIA PACIFIC SOLVENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 31 ASIA PACIFIC SOLVENTS PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 32 ASIA PACIFIC EMOLLIENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 33 ASIA PACIFIC EMOLLIENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 34 ASIA PACIFIC GLIDENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 35 ASIA PACIFIC GLIDENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 36 ASIA PACIFIC CHELATING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 37 ASIA PACIFIC CHELATING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 38 ASIA PACIFIC ANTIFOAMING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 39 ASIA PACIFIC ANTIFOAMING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 40 ASIA PACIFIC OTHERS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 41 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET, BY DOSAGE FORM, 2015-2029 (USD MILLION)
TABLE 42 ASIA PACIFIC SOLID IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 43 ASIA PACIFIC SOLID IN PHARMACEUTICAL EXCIPIENTS MARKET, BY DOSAGE FORM, 2015-2029 (USD MILLION)
TABLE 44 ASIA PACIFIC SEMI-SOLID IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 45 ASIA PACIFIC SEMI-SOLID IN PHARMACEUTICAL EXCIPIENTS MARKET, BY DOSAGE FORM, 2015-2029 (USD MILLION)
TABLE 46 ASIA PACIFIC LIQUID IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 47 ASIA PACIFIC LIQUID IN PHARMACEUTICAL EXCIPIENTS MARKET, BY DOSAGE FORM, 2015-2029 (USD MILLION)
TABLE 48 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2029 (USD MILLION)
TABLE 49 ASIA PACIFIC ORAL EXCIPIENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 50 ASIA PACIFIC TOPICAL EXCIPIENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 51 ASIA PACIFIC PARENTERAL EXCIPIENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 52 ASIA PACIFIC OTHER EXCIPIENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 53 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2015-2029 (USD MILLION)
TABLE 54 ASIA PACIFIC DIRECT TENDER IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 55 ASIA PACIFIC DIRECT TENDER IN PHARMACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2015-2029 (USD MILLION)
TABLE 56 ASIA PACIFIC RETAIL SALES IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 57 ASIA PACIFIC OTHERS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 58 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET, BY END USER, 2015-2029 (USD MILLION)
TABLE 59 ASIA PACIFIC PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 60 ASIA PACIFIC CONTRACT FORMULATORS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 61 ASIA PACIFIC RESEARCH ORGANIZATION AND ACADEMICS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 62 ASIA PACIFIC OTHERS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
List of Figure
FIGURE 1 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: MULTIVARIATE MODELLING
FIGURE 7 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: MARKET END USER COVERAGE GRID
FIGURE 10 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: SEGMENTATION
FIGURE 12 THE RISE IN GENERIC DRUG PRODUCTION AND TECHNOLOGICAL FOCUS ON PHARMACEUTICAL EXCIPIENTS IS DRIVING THE ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 13 THE BINDERS AND ADHESIVES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET IN 2022 & 2029
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET
FIGURE 15 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET : BY FUNCTIONALITY, 2021
FIGURE 16 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET : BY FUNCTIONALITY, 2022-2029 (USD MILLION)
FIGURE 17 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET : BY FUNCTIONALITY, CAGR (2022-2029)
FIGURE 18 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET : BY FUNCTIONALITY, LIFELINE CURVE
FIGURE 19 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: BY DOSAGE FORM, 2021
FIGURE 20 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: BY DOSAGE FORM, 2022-2029 (USD MILLION)
FIGURE 21 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: BY DOSAGE FORM, CAGR (2022-2029)
FIGURE 22 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: BY DOSAGE FORM, LIFELINE CURVE
FIGURE 23 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, 2021
FIGURE 24 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, 2022-2029 (USD MILLION)
FIGURE 25 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2022-2029)
FIGURE 26 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 27 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 28 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 29 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 30 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 31 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET : BY END USER, 2021
FIGURE 32 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET : BY END USER, 2022-2029 (USD MILLION)
FIGURE 33 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET : BY END USER, CAGR (2022-2029)
FIGURE 34 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET : BY END USER, LIFELINE CURVE
FIGURE 35 ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: SNAPSHOT (2021)
FIGURE 36 ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: BY COUNTRY (2021)
FIGURE 37 ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 38 ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 39 ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: BY FUNCTIONALITY (2022-2029)
FIGURE 40 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY SHARE 2021 (%)
